tiprankstipranks
Trending News
More News >
Capricor Therapeutics (CAPR)
NASDAQ:CAPR

Capricor Therapeutics (CAPR) Revenue

Compare
1,261 Followers

Capricor Therapeutics Revenue

Capricor Therapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 11.13M, Increased -16.89%. In the fiscal year ending Dec 31, 2024, Capricor Therapeutics had annual revenue of 22.27M with -11.55% growth.
Revenue (ttm)
11.13M
Revenue Growth
-52.08%
P/S Ratio
68.15
Revenue/Employee
$139,190
Employees
160
Market Cap
$1.52B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
22.27M-2.91M-11.55%
Dec 31, 2023
25.18M22.63M+886.81%
Dec 31, 2022
2.55M2.31M+941.85%
Dec 31, 2021
244.90K-65.35K-21.06%
Dec 31, 2020
310.25K-694.78K-69.13%
Dec 31, 2019
1.01M-665.97K-39.85%
Dec 31, 2018
1.67M-995.00K-37.32%
Dec 31, 2017
2.67M